This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS).
This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS). Adult patients scheduled for elective VATS who meet the eligibility criteria will be randomized to either Arm: Arm 1: General anesthesia with TPVB; Arm 2: General anesthesia alone (control group). Primary Outcome: to assess Opioid requirement in the PACU
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
81
0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space
King Hussein Cancer Center
Amman, Jordan
Opioid requirement in the PACU
Opioid requirement in the PACU, recorded as "yes" or "no."
Time frame: Opioid requirement assessed at 5 minutes, 15 minutes, 30 minutes post-PACU admission, and at PACU discharge (up to 4 hours)
Pain intensity measured by Numeric Rating Scale -NRS
Pain intensity measured by Numeric Rating Scale- NRS at several time points, Range: 0 (no pain) to 10 (worst imaginable pain), Interpretation: Higher scores indicate worse pain intensity
Time frame: Pain intensity measured using the Numeric Rating Scale (NRS) at 5 minutes, 15 minutes, 30 minutes post-PACU admission, and at PACU discharge (up to 4 hours)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.